Skip to main content

A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections

  • M. LI-NG (a1), J. F. ALOIA (a1), S. POLLACK (a1), B. A. CUNHA (a2), M. MIKHAIL (a1), J. YEH (a1) and N. BERBARI (a3)...

Vitamin D has been shown to be an important immune system regulator. Vitamin D insufficiency during winter may cause increased susceptibility to upper respiratory tract infections (URIs). To determine whether vitamin D supplementation during the winter season prevents or decreases URI symptoms, 162 adults were randomized to receive 50 μg vitamin D3 (2000 IU) daily or matching placebo for 12 weeks. A bi-weekly questionnaire was used to record the incidence and severity of URI symptoms. There was no difference in the incidence of URIs between the vitamin D and placebo groups (48 URIs vs. 50 URIs, respectively, P=0·57). There was no difference in the duration or severity of URI symptoms between the vitamin D and placebo groups [5·4±4·8 days vs. 5·3±3·1 days, respectively, P=0·86 (95% CI for the difference in duration −1·8 to 2·1)]. The mean 25-hydroxyvitamin D level at baseline was similar in both groups (64·3±25·4 nmol/l in the vitamin D group; 63·0±25·8 nmol/l in the placebo group; n.s.). After 12 weeks, 25-hydroxyvitamin D levels increased significantly to 88·5±23·2 nmol/l in the vitamin D group, whereas there was no change in vitamin D levels in the placebo group. There was no benefit of vitamin D3 supplementation in decreasing the incidence or severity of symptomatic URIs during winter. Further studies are needed to determine the role of vitamin D in infection.

Corresponding author
*Author for correspondence: J. F. Aloia, M.D., Winthrop University Hospital, 222 Station Plaza North, Suite 510, Mineola, NY 11501, USA. (Email:
Hide All
1. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. American Journal of Clinical Nutrition 2004; 80: 1706S1709S.
2. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. Journal of Clinical Endocrinology and Metabolism 2003; 88: 57665772.
3. Bertone-Johnson ER, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiology Biomarkers & Prevention 2005; 14: 19911997.
4. Lappe JM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. American Journal of Clinical Nutrition 2007; 85: 15861591.
5. Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occupational & Environmental Medicine 2002; 59: 257262.
6. Schmidt-Gayk H., et al. Serum 25-hydroxycalciferol in myocardial infarction. Atherosclerosis 1977; 26: 5558.
7. Cutolo M, et al. Vitamin D in rheumatoid arthritis. Autoimmunity Reviews 2007; 7: 5964.
8. Cutolo M, Otsa K. Vitamin D, immunity and lupus [Review]. Lupus 2008; 17: 610.
9. Wang TT, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology 2004; 173: 29092912.
10. Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nature Reviews Immunology 2006; 6: 447456.
11. Leikina E, et al. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nature Immunology 2005; 6: 9951001.
12. Liu PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 17701773.
13. Harris SS, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. American Journal of Clinical Nutrition 1998; 67: 12321236.
14. Hope-Simpson RE, Golubev DB. A new concept of the epidemic process of influenza A virus. Epidemiology and Infection 1987; 99: 554.
15. Hope-Simpson RE. The Transmission of Epidemic Influenza. New York: Plenum Press, 1992.
16. Fendrick AM, et al. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Archives of Internal Medicine 2003; 163: 487494.
17. Centers for Disease Control and Prevention. Key facts about influenza and influenza vaccine ( Accessed 1 February 2008.
18. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. Journal of Cell Biochemistry 1992; 49: 2631.
19. Schleithoff SS, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition 2006; 83: 754759.
20. Aloia JF, et al. A randomized controlled trial of vitamin D3 supplementation in African American women. Archives of Internal Medicine 2005; 165: 16181623.
21. Institute of Medicine, Food and Nutrition Board. 1999 Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academy Press.
22. Heaney RP, et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. American Journal of Clinical Nutrition 2003; 77: 204210.
23. Vieth R, et al. The urgent need to recommend an intake of vitamin D that is effective. American Journal of Clinical Nutrition 2007; 85: 649650.
24. Chubak J, et al. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. American Journal of Medicine 2006; 119: 937942.
25. Nieman DC, et al. Physical activity and immune function in elderly women. Medicine & Science in Sports & Exercise 1993; 25: 823831.
26. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. American Journal of Clinical Nutrition 2001; 73: 288294.
27. Laaksi I, et al. An association of serum vitamin D concentrations <40 nmol/l with acute respiratory tract infection in young Finnish men. American Journal of Clinical Nutrition 2007; 86: 714717.
28. Avenell A, et al. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people [RECORD trial, ISRCTN 51647438]. Age and Ageing 2007; 36: 574577.
29. New York State Department of Health. ( Accessed 1 February 2008.
30. Centers for Disease Control and Prevention. 2006–07 U.S. influenza season summary ( Accessed 1 February 2008.
31. Barger-Lux MJ, et al. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporosis International 1998; 8: 222230.
32. Looker AC, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002; 30: 771777.
33. Trang HM, et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. American Journal of Clinical Nutrition 1998; 68: 854858.
34. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. American Journal of Clinical Nutrition 2006; 84: 694697.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Li-Ng supplementary material

 Word (22 KB)
22 KB


Altmetric attention score

Full text views

Total number of HTML views: 19
Total number of PDF views: 110 *
Loading metrics...

Abstract views

Total abstract views: 853 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd February 2018. This data will be updated every 24 hours.